Improved Real-life Adherence of 6-monthly Denosumab Injections due to Positive Feedback based on Rapid 6-months BMD Increase and Good Safety Profile - Ringe, JD; Farahmand, P (Rheumtol Int)
DOI 10.1007/s00 296 012-2663-2.